Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Primary Breast Cancer
Interventions: DRUG: Epirubicin, Carboplatin, Docetaxel
Sponsor: Klinikum Weissenfels